INTRODUCTION: Trans-fatty acids (TFAs) can be produced either from bio-hydrogenation in the rumen of ruminants or by industrial hydrogenation. While most of TFAs' effects from ruminants are poorly established, there is increasing evidence that high content of industrial TFAs may cause deleterious effects on human health and life span. MATERIAL AND METHODS: Indeed, several epidemiological and experimental studies strongly suggest that high content of most TFA isomers could represent a higher risk of developing cardiovascular diseases by a mechanism that lowers the "good HDL cholesterol" and raises the "bad LDL cholesterol." RESULTS: With respect to the general precautionary principle and considering the existence of an international policy consensus regarding the need for public health action, some industrialized countries, such as France, are still not sufficiently involved in preventive strategies that aim to efficiently reduce TFAs content and TFAs consumption and produce alternative healthier fat sources. CONCLUSION: In this manuscript, we provide an overview about TFAs origins, their use and consumption among French population. We also discuss their potential human health implications as well as the preventive and regulatory measures undertaken in France.
INTRODUCTION:Trans-fatty acids (TFAs) can be produced either from bio-hydrogenation in the rumen of ruminants or by industrial hydrogenation. While most of TFAs' effects from ruminants are poorly established, there is increasing evidence that high content of industrial TFAs may cause deleterious effects on human health and life span. MATERIAL AND METHODS: Indeed, several epidemiological and experimental studies strongly suggest that high content of most TFA isomers could represent a higher risk of developing cardiovascular diseases by a mechanism that lowers the "good HDL cholesterol" and raises the "bad LDL cholesterol." RESULTS: With respect to the general precautionary principle and considering the existence of an international policy consensus regarding the need for public health action, some industrialized countries, such as France, are still not sufficiently involved in preventive strategies that aim to efficiently reduce TFAs content and TFAs consumption and produce alternative healthier fat sources. CONCLUSION: In this manuscript, we provide an overview about TFAs origins, their use and consumption among French population. We also discuss their potential human health implications as well as the preventive and regulatory measures undertaken in France.
Authors: F B Hu; M J Stampfer; J E Manson; E Rimm; G A Colditz; B A Rosner; C H Hennekens; W C Willett Journal: N Engl J Med Date: 1997-11-20 Impact factor: 91.245
Authors: Corinne Malpuech-Brugère; Wilhelmine P H G Verboeket-van de Venne; Ronald P Mensink; Marie-Agnès Arnal; Béatrice Morio; Marion Brandolini; Asgeir Saebo; Taous S Lassel; Jean Michel Chardigny; Jean Louis Sébédio; Bernard Beaufrère Journal: Obes Res Date: 2004-04
Authors: Anu M Turpeinen; Marja Mutanen; Antti Aro; Irma Salminen; Samar Basu; Donald L Palmquist; J Mikko Griinari Journal: Am J Clin Nutr Date: 2002-09 Impact factor: 7.045
Authors: Jeyachchandran Visvalingam; Payam Vahmani; David C Rolland; Michael E R Dugan; Xianqin Yang Journal: Lipids Date: 2017-06-17 Impact factor: 1.880
Authors: Marie C Conway; Emeir M McSorley; Maria S Mulhern; Toni Spence; Edwin van Wijngaarden; Gene E Watson; Karin Wahlberg; Daniela Pineda; Karin Broberg; Barry W Hyland; Diego F Cobice; J J Strain; Alison J Yeates Journal: Eur J Nutr Date: 2020-07-28 Impact factor: 5.614